Answers are grounded in this paper and cite their sources.
A practical method for the synthesis of 2-alkyl- and 2-arylthiazolo[5,4-c]isoquinoline derivatives starting from simple commercially available reagents is presented. The recently reported La(OTf)3 catalysed reaction of dithiooxamide with 2-halobenzaldehydes to afford 2-arylthiazolo[5,4-c]isoquinolines is now extended to the synthesis of 2-alkylthiazolo[5,4-c]isoquinolines and "mixed" 2-arylthiazolo[5,4-c]isoquinolines. The new compounds can be prepared under the previously reported experimental conditions but using a 1:1 mixture of a 2-halobenzaldehyde and an aliphatic or (hetero)aromatic aldehyde. The new approach also allows the access to 2-alkyl-5-arylthiazolo[5,4-d]thiazoles that are hitherto unknown structures. The single-crystal X-ray diffraction structures of three thiazolo[5,4-c]isoquinolines and of two non-symmetrical thiazolo[5,4-d]thiazoles are presented. The photophysical properties of the new thiazolo[5,4-c]isoquinoline derivatives, and their potential biological activities and toxicological risks, are discussed. Some of the new compounds show interesting bioactivity scores as kinase inhibitors.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: